Steroid medications are not the primary cause of bone death in liver transplant patients, according to a 2026 study of 1,836 transplant recipients. Instead, patients who were malnourished or had specific liver diseases before surgery faced 3 to 4 times higher risk. Gram Research analysis found that pre-transplant health status and nutritional status predicted bone complications better than steroid exposure, suggesting doctors should focus on identifying and supporting vulnerable patients before transplant.
Researchers studied 1,836 liver transplant patients to understand why some develop osteonecrosis, a serious bone condition where bone tissue dies. Surprisingly, Gram Research analysis found that steroid medications, long blamed for this problem, weren’t the main culprit. Instead, patients who were malnourished before surgery or had certain liver diseases like primary biliary cholangitis faced much higher risk. About 3.5% of patients developed this bone disease, and nearly 72% needed surgery to fix it. The findings suggest doctors should pay special attention to patients who were frail or undernourished before their transplant.
Key Statistics
A 2026 cohort study of 1,836 liver transplant patients found that osteonecrosis developed in 64 patients (3.5%), with 71.9% requiring surgical intervention.
Patients with primary biliary cholangitis or Wilson disease had 4.21 times higher risk of bone death after liver transplant compared to other patients, according to the 2026 study.
Patients requiring enteral nutrition support before liver transplant had 2.98 times higher risk of developing osteonecrosis, independent of steroid exposure.
Steroid medication dose in the first three months after liver transplant showed no significant association with bone death risk in the 1,836-patient cohort study.
The Quick Take
- What they studied: Why some liver transplant patients develop osteonecrosis, a condition where bone in the hip dies and can collapse, requiring surgery
- Who participated: 1,836 adults who received their first liver transplant between 2000 and 2023 at various medical centers
- Key finding: Steroid medications were not the main cause of bone death after transplant. Instead, patients who were malnourished before surgery or had specific liver diseases had 3 to 4 times higher risk of developing this serious bone problem
- What it means for you: If you’re facing a liver transplant, your doctors should assess your nutrition and overall health before surgery. This information helps identify who needs extra monitoring for bone problems after transplant, though most patients (96.5%) never develop this condition
The Research Details
Researchers looked back at medical records from 1,836 patients who had liver transplants over 23 years. They carefully tracked how much steroid medication each patient received in the first three months after surgery and watched to see who developed bone death. They used special statistical methods to avoid common mistakes that happen when studying things that develop over time. The researchers also looked at other factors like patients’ weight, nutrition status, smoking history, and what liver disease they had before transplant.
This type of study, called a retrospective cohort study, is like being a detective looking through old case files. It’s very useful for understanding rare complications because researchers can study many patients over a long time. However, it can’t prove that one thing directly causes another the way an experiment can. The strength of this study is its large size and the detailed medical information available for each patient.
For decades, doctors assumed steroid medications caused bone death after liver transplant because steroids are known to weaken bones. But modern transplant medicine uses different combinations of medications than in the past. This study helps clarify whether steroids are still the main problem or if other factors matter more. Understanding the real causes helps doctors prevent this serious complication and identify which patients need extra care and monitoring.
This study has several strengths: it included a large number of patients (1,836), followed them for many years, and used careful statistical methods to avoid common errors. The researchers adjusted their analysis for many different factors that could influence the results. However, because it looked backward at medical records rather than following patients forward, some information might be incomplete. The study also comes from a specialized transplant center, so results might differ slightly at other hospitals. The findings are consistent across different statistical approaches, which makes them more trustworthy.
What the Results Show
Among 1,836 liver transplant patients, 64 developed osteonecrosis (bone death), which is 3.5% of the group. On average, this bone disease appeared about 5.9 years after transplant. The most striking finding was that steroid dose in the first three months after surgery did not predict who would develop bone death. Even when researchers used advanced statistical methods to account for timing and other factors, steroids remained unrelated to bone death risk.
Instead, certain pre-transplant factors strongly predicted bone death. Patients with primary biliary cholangitis or Wilson disease (two specific liver diseases) had 4.2 times higher risk. Patients who needed tube feeding or special nutrition support before surgery had 3 times higher risk. These findings suggest that patients’ overall health and nutrition status before transplant matters more than steroid exposure after transplant.
The consequences were serious: 71.9% of patients who developed bone death needed surgery to repair or replace the damaged bone. This means that identifying high-risk patients before transplant could allow doctors to monitor them more closely and catch problems early.
Two additional factors showed suggestive but not definitive associations with bone death. Patients with higher cumulative smoking exposure had somewhat elevated risk, though this didn’t quite reach statistical significance. Similarly, patients whose liver disease severity scores were higher before transplant showed a trend toward increased risk. These findings hint that overall health and lifestyle factors may contribute to bone death risk, though more research is needed to confirm these connections.
This study challenges the long-standing assumption that steroids are the primary cause of bone death after liver transplant. Previous research from the 1990s and early 2000s strongly implicated steroids, but transplant protocols have changed significantly since then. Modern immunosuppressive regimens use lower steroid doses and different medication combinations. This research suggests that as steroid use has decreased, other factors like pre-transplant nutritional status have become relatively more important. The findings align with emerging research showing that frailty and malnutrition before major surgery predict many post-operative complications.
This study looked backward at medical records rather than following patients forward, which means some information might be missing or recorded differently over time. The study included patients from 2000 to 2023, spanning different eras of transplant medicine, so practices changed during the study period. Bone death is relatively rare (3.5%), so even with 1,836 patients, the researchers had only 64 cases to study, which limits their ability to detect smaller effects. The study comes from specialized transplant centers, so results might not apply exactly to all hospitals. Finally, the researchers couldn’t randomly assign patients to different steroid doses, so they can’t prove that steroids don’t cause bone death, only that they didn’t find a strong association in this group.
The Bottom Line
If you’re awaiting liver transplant, work with your medical team to optimize your nutrition and overall health before surgery. This includes addressing malnutrition, maintaining healthy weight, and managing any other health conditions. After transplant, follow your doctor’s instructions about medications and attend all follow-up appointments. Report any hip or groin pain to your transplant team promptly, as early detection of bone problems allows for better treatment options. These recommendations are based on solid evidence from a large study, though individual results vary.
Liver transplant patients and their families should understand this information, especially those with primary biliary cholangitis, Wilson disease, or malnutrition before transplant. Transplant surgeons and hepatologists should use these findings to identify high-risk patients and plan closer monitoring. People considering liver transplant should discuss bone health with their transplant team. However, this research doesn’t change care for most patients, since bone death remains uncommon (affecting only 3.5% of transplant recipients).
Bone death typically appears 5 to 6 years after transplant, though it can develop earlier or later. Most patients who develop this condition do so within the first 10 years after transplant. Symptoms like hip pain may develop gradually over months. If surgery is needed, recovery typically takes several months. This timeline means transplant patients should remain vigilant about bone health for at least a decade after their procedure.
Frequently Asked Questions
Do steroids cause bone problems after liver transplant?
Steroids were long blamed for bone death after liver transplant, but a 2026 study of 1,836 patients found no significant link between steroid dose and bone complications. Pre-transplant malnutrition and certain liver diseases posed greater risk.
What increases the risk of osteonecrosis after liver transplant?
Malnutrition before surgery and specific liver diseases like primary biliary cholangitis or Wilson disease significantly increase risk. Patients needing tube feeding before transplant had nearly 3 times higher risk of developing bone death.
How common is bone death after liver transplant?
Osteonecrosis affects approximately 3.5% of liver transplant patients, developing on average 5.9 years after surgery. Most patients who develop it eventually need surgery to repair the damaged bone.
Can doctors predict who will get bone problems after transplant?
Yes, patients with certain pre-transplant characteristics face higher risk: those with primary biliary cholangitis, Wilson disease, malnutrition, or poor overall health status. Identifying these patients before surgery allows for closer monitoring.
What should transplant patients do to prevent bone disease?
Optimize nutrition and overall health before transplant, maintain healthy weight, avoid smoking, and report any hip or groin pain to your transplant team promptly. Regular follow-up appointments and medication adherence are essential.
Want to Apply This Research?
- Log any hip, groin, or thigh pain with location, intensity (1-10 scale), and activity that triggered it. Track this weekly or whenever pain occurs. Include notes about what makes pain better or worse.
- Set monthly reminders to check in with your transplant team about bone health. Record your steroid dose and other medications. Note any changes in mobility or difficulty with stairs, walking, or sitting. Share this log with your transplant doctor at each visit.
- Create a long-term bone health tracker that records pain episodes, physical activity level, and medication adherence for the first 10 years after transplant. Set annual reminders to discuss bone health screening with your doctor. Flag any new or worsening pain for immediate medical attention.
This article summarizes research findings and should not replace medical advice from your transplant team. Osteonecrosis is a serious complication requiring professional medical evaluation and treatment. If you have had a liver transplant and experience hip, groin, or thigh pain, contact your transplant surgeon or hepatologist immediately. Individual risk factors vary, and this research applies to population trends, not necessarily to any single patient. Always discuss bone health concerns and screening options with your transplant medical team.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.